Terms: = Liver cancer AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
144 results:
1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract] [Full Text] [Related]
2. SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea.
Cho HJ; Lee E; Kim SS; Cheong JY
Sci Rep; 2024 Apr; 14(1):9761. PubMed ID: 38684838
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of prognosis and background liver disease in non-advanced hepatocellular carcinoma in two decades.
Kaneko S; Asahina Y; Murakawa M; Azuma S; Inada K; Mochida T; Watakabe K; Shimizu T; Tsuchiya J; Miyoshi M; Kawai-Kitahata F; Nitta S; Takahashi M; Fujioka T; Kishino M; Anzai T; Kakinuma S; Nakagawa M; Okamoto R
PLoS One; 2024; 19(3):e0297882. PubMed ID: 38452155
[TBL] [Abstract] [Full Text] [Related]
4. Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation.
Zhu JQ; Zhu Y; Qi M; Zeng Y; Liu ZJ; Ding C; Zhang T; Li XL; Han DD; He Q
Cancer Immunol Immunother; 2024 Feb; 73(3):58. PubMed ID: 38386050
[TBL] [Abstract] [Full Text] [Related]
5. The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis.
Tsilimigras DI; Endo Y; Ratti F; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Kitago M; Guglielmi A; Hugh T; Aldrighetti L; Gleisner A; Shen F; Endo I; Pawlik TM
HPB (Oxford); 2024 Apr; 26(4):541-547. PubMed ID: 38218690
[TBL] [Abstract] [Full Text] [Related]
6. A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [
Lv J; Yu H; Yin H; Shi Y; Shi H
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):919-927. PubMed ID: 37940684
[TBL] [Abstract] [Full Text] [Related]
7. Bavachin combined with epimedin B induce idiosyncratic liver injury under immunological stress conditions.
Lin M; Li Y; Cao B; Xu J; Zhang Y; Li G; Xiao X; Li C
Chem Biol Interact; 2023 Dec; 386():110774. PubMed ID: 37866487
[TBL] [Abstract] [Full Text] [Related]
8. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study.
Xiang C; Shen X; Zeng X; Zhang Y; Ma Z; Zhang G; Song X; Huang T; Yang J
Int J Surg; 2024 Jan; 110(1):315-323. PubMed ID: 37812183
[TBL] [Abstract] [Full Text] [Related]
9. Ultrasound identification of hepatic echinococcosis using a deep convolutional neural network model in China: a retrospective, large-scale, multicentre, diagnostic accuracy study.
Yang Y; Cairang Y; Jiang T; Zhou J; Zhang L; Qi B; Ma S; Tang L; Xu D; Bu L; Bu R; Jing X; Wang H; Zhou Z; Zhao C; Luo B; Liu L; Guo J; Nima Y; Hua G; Wa Z; Zhang Y; Zhou G; Jiang W; Wang C; De Y; Yu X; Cheng Z; Han Z; Liu F; Dou J; Feng H; Wu C; Wang R; Hu J; Yang Q; Luo Y; Wu J; Fan H; Liang P; Yu J
Lancet Digit Health; 2023 Aug; 5(8):e503-e514. PubMed ID: 37507196
[TBL] [Abstract] [Full Text] [Related]
10. Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study.
Reddy KR; McLerran D; Marsh T; Parikh N; Roberts LR; Schwartz M; Nguyen MH; Befeler A; Page-Lester S; Tang R; Srivastava S; Rinaudo JA; Feng Z; Marrero JA
Gastroenterology; 2023 Oct; 165(4):1053-1063.e6. PubMed ID: 37429366
[TBL] [Abstract] [Full Text] [Related]
11. Interstitial Brachytherapy for Hepatocellular Carcinoma: Analysis of Prognostic Factors for Overall Survival and Progression-Free Survival and Application of a Risk Stratification Model.
Thormann M; Heitmann F; Wrobel V; Heinze C; March C; Hass P; Damm R; Surov A; Pech M; Omari J
Dig Dis; 2023; 41(6):957-966. PubMed ID: 37385234
[TBL] [Abstract] [Full Text] [Related]
12. Joint liver and hepatic lesion segmentation in MRI using a hybrid CNN with transformer layers.
Hille G; Agrawal S; Tummala P; Wybranski C; Pech M; Surov A; Saalfeld S
Comput Methods Programs Biomed; 2023 Oct; 240():107647. PubMed ID: 37329803
[TBL] [Abstract] [Full Text] [Related]
13. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis.
VoPham T; Cravero A; Feld LD; Green P; Feng Z; Berry K; Kim NJ; Vutien P; Mendoza JA; Ioannou GN
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1069-1078. PubMed ID: 37255388
[TBL] [Abstract] [Full Text] [Related]
14. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
Park MK; Lee DH; Hur BY; Lee HC; Lee YB; Yu SJ; Kim YJ; Yoon JH; Lee JH
Radiology; 2023 Jun; 307(5):e222106. PubMed ID: 37249427
[TBL] [Abstract] [Full Text] [Related]
15. Regorafenib compared to nivolumab after sorafenib failure in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Yang S; Zhou Y; Zeng L
Adv Clin Exp Med; 2023 Aug; 32(8):839-845. PubMed ID: 37140014
[TBL] [Abstract] [Full Text] [Related]
16. PINK1 Immunoexpression Predicts Survival in Patients Undergoing Hepatic Resection for Colorectal liver Metastases.
Celis-Pinto JC; Fernández-Velasco AA; Corte-Torres MD; Santos-Juanes J; Blanco-Agudín N; Piña Batista KM; Merayo-Lloves J; Quirós LM; Fernández-Vega I
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047483
[TBL] [Abstract] [Full Text] [Related]
17. Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.
Xiao R; Ni C; Cai Y; Zhou Y; Gong X; Xie K; You J
Endocrine; 2023 Jun; 80(3):619-629. PubMed ID: 36696026
[TBL] [Abstract] [Full Text] [Related]
18. Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinoma.
Xu L; Xu Y; Li G; Yang B
Eur J Med Res; 2022 Dec; 27(1):280. PubMed ID: 36494837
[TBL] [Abstract] [Full Text] [Related]
19. Clinical-radiomics predictors to identify the suitability of transarterial chemoembolization treatment in intermediate-stage hepatocellular carcinoma: A multicenter study.
Wang DD; Zhang JF; Zhang LH; Niu M; Jiang HJ; Jia FC; Feng ST
Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):594-604. PubMed ID: 36456428
[TBL] [Abstract] [Full Text] [Related]
20. Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model.
He Y; Liang T; Chen Z; Mo S; Liao Y; Gao Q; Huang K; Peng T; Zhou W; Han C
Oxid Med Cell Longev; 2022; 2022():7261786. PubMed ID: 36238647
[TBL] [Abstract] [Full Text] [Related]
[Next]
